首页> 外文期刊>Expert opinion on biological therapy >Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine
【24h】

Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine

机译:新型艾滋病疫苗的开发:转录蛋白疫苗的HIV-1反式激活剂

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Classical approaches aimed at targeting the HIV-1 envelope as well as other structural viral proteins have largely failed. The HIV-1 transactivator of transcription (Tat) is a key HIV virulence factor, which plays pivotal roles in virus gene expression, replication, transmission and disease progression. Notably, anti-Tat Abs are uncommon in natural infection and, when present, correlate with the asymptomatic state and lead to lower or no disease progression. Hence, targeting Tat represents a pathogenesis-driven intervention.
机译:简介:旨在靶向HIV-1包膜以及其他结构性病毒蛋白的经典方法在很大程度上失败了。 HIV-1转录反式激活因子(Tat)是关键的HIV毒力因子,它在病毒基因表达,复制,传播和疾病进展中起关键作用。值得注意的是,抗Tat抗体在自然感染中并不常见,如果存在,则与无症状状态相关,导致疾病进展较低或无进展。因此,靶向Tat代表了发病机制驱动的干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号